Authors :
Aqeel Ahmad Khan; Suboohi Irshad; Shaista Parveen S.; Javed Ahamd Khan; Shabir Ahmad Parray; Shagufta Nikhat
Volume/Issue :
Volume 10 - 2025, Issue 8 - August
Google Scholar :
https://tinyurl.com/j92xfjv7
Scribd :
https://tinyurl.com/ya3pa4tr
DOI :
https://doi.org/10.38124/ijisrt/25aug223
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Note : Google Scholar may take 30 to 40 days to display the article.
Abstract :
A randomized, single-blind, standard-controlled clinical trial was conducted to assess the therapeutic efficacy of
Anjeer (Ficus carica) in the management of Type 2 Diabetes Mellitus (T2DM), traditionally referred to as Ziabetus Shakri.
Sixty confirmed T2DM patients were randomly assigned into two groups: Group A (Test) and Group B (Control), with 30
participants in each. Group A received the investigational drug (Ficus carica) at a dosage of 3 grams twice daily, while Group
B was administered Metformin 500 mg (Cipla), one tablet twice daily, over a period of 45 days.
The findings demonstrated that the test formulation significantly improved certain subjective symptoms, including
fatigue (p<0.001) and unexplained weight loss (p<0.01). However, no statistically significant changes were observed in
polyuria, polydipsia, polyphagia, or progressive weakness (p>0.05). Regarding objective parameters, Group A exhibited
notable improvements in fasting blood sugar (FBS), postprandial blood sugar (PPBS), urine glucose levels (p<0.01), and
glycated hemoglobin (HbA1c) (p<0.05). In contrast, the control group did not show statistically significant changes in FBS
and urine glucose (p>0.05).
These results suggest that Ficus carica may offer potential as an adjunctive treatment for T2DM, particularly in
alleviating specific clinical symptoms and improving glycemic control.
Keywords :
Ziabetus Shakari, Diabetic Mellitus, Anjeer, Metformin, HbA1c.
References :
- Ibn-e-Sina. Al Qanoon fil Tib (Urdu Translation by Kantoori GH). Vol.1 & 3. Lucknow: Matba Munshi Naval Kishore; 1927: 207-211, 112.
- Majusi Ali bin Abbas. Kamil Al Sana’ah (urdu translation by Kanturi GH). Vol.1 & 2. Lucknow: Matba Munshi Nawal Kishore; 1989: 228-232, 409-410.
- Jurjani. Zakhira Khwarzam Shahi (Urdu): Idara-e-Kitab-ul- Shifa, New Delhi: 2010: Vol. 3: 98-101.
- Rabban Tabri. Firdaus-ul-Hikmat (Urdu). Hamdard Foundation: Karachi: 1981: 315-317.
- Aazam M. Akseere Aazam, Vol.3. Lucknow: Matba Munshi Naval Kishore: 446-447.
- Sanders LJ. From Thebes to Toronto and the 21st century: An Incredible Journey. Diabetes Spectrum 2002; 15(1): 56-60.
- (Jani DK, Nesari MT, Vijayakumar D, Loriaux, Lynn D. Diabetes and the Ebers Papyrus: 1552 BC. The Endocrinologist 2006; 16(2): 55-6.
- Barthold SW. Unsung heroes in the battle against diabetes. ILAR: 2004; 45; 227-30.
- Park K. Park’s Text Book of Preventive and Social Medicine. 20th ed. Jabalpur India: Banarasidas Bhanot; 2009: 341-345.
- Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. International Diabetes Federation, 3rd ed. Belgium: 2006; 15-103.
- Gupta OP, Pathak S. Pandemic trend in prevalence of diabetes mellitus and associated coronary heart disease in India: Their cause and presentation. Internal. Jour. Of Diab in developing countries 2003; 23: 37-49.
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes. Diabetes Care 2004; 27 (5): 1047-1053.
- Ayyub Ali S. Tarjuma Zakhira Sabit Bin Qurrah. Aligharh: Litho Printers; 1987: 280.
- Qarshi MH. Jamiul Hikmat. Vol. II. Lahore: Shaikh Mohammad Bashir & Sons; YNM: 378-379.
- Khan M Ajmal. Haziq. Delhi: Jaseem Book Depot; 1983: 383-390.
- Jeelani G. Makhzane Hikmat, Vol. II. Lahore: Shaikh Mohammad Bashir Sons; 1996: 63-88.
- Khan A. Bayaze Ajmal. New Delhi: Aijaz Publishing House; 1995: 146-147.
- Nikhat S, Khan JA, Ahmad G. Some Experimentally Proved Herbs in Peptic Ulcer Disease. IJPSR, 2012; Vol. 3(8): 2387-2392.
- Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population-based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health 2000; 54: 173–177.
- Shamkant B. Badgujar, Vainav V. Patel, Atmaram H. Bandivdekar & Raghunath T. Mahajan. Traditional uses, phytochemistry and pharmacology of Ficus carica: A review, Pharmaceutical Biology, 2014; 52(11): 1487-1503
- Iffat Ara, Syeda Hina Naqvi, Najeeb Ur Rehman and Mohammad Moiz Qureshi, Comparative Antioxidative and Antidiabetic Activities of Ficus Carica Pulp, Peel and Leaf and their Correlation with Phytochemical Contents. Pharm Res 2020, 4(2): 000197.
- Ibn Hubal. Kitabul Mukhtarat Fil Tibb, (Urdu translation by CCRUM). 2nd. New Delhi: Ministry of H & FW, Govt. of India; 2004:
- Ghani N. Khazainul Advia. New Delhi: Idarae Kitabul Shifa; YNM:
- Nadkarni KM. Indian Plants and Drugs. New Delhi: Srishti Book Distributors; 2005: 120.
- Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Vol.5th. Dehradun: Oriental Enterprises; 2003:
- Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. 6th ed. New Delhi: National Institute of Science Communication and Information Resources CSIR; 2002.
- Ibne Al Baytar. Al Jami Li Mufradat Al Adviya wal Aghziya, (Urdu translation by CCRUM). Vol. Ist. New Delhi: Ministry of H & FW, Govt. of India; 2003.
- Ibn-e-Sina. Al Qanoon fil Tib (Urdu Translation by Kantoori GH). Vol.1 & 3. Lucknow: Matba Munshi Naval Kishore; 1927: 207-211, 112.
- Majusi Ali bin Abbas. Kamil Al Sana’ah (urdu translation by Kanturi GH). Vol.1 & 2. Lucknow: Matba Munshi Nawal Kishore; 1989: 228-232, 409-410.
- Jurjani. Zakhira Khwarzam Shahi (Urdu): Idara-e-Kitab-ul- Shifa, New Delhi: 2010: Vol. 3: 98-101.
- Rabban Tabri. Firdaus-ul-Hikmat (Urdu). Hamdard Foundation: Karachi: 1981: 315-317.
- Aazam M. Akseere Aazam, Vol.3. Lucknow: Matba Munshi Naval Kishore: 446-447.
- Sanders LJ. From Thebes to Toronto and the 21st century: An Incredible Journey. Diabetes Spectrum 2002; 15(1): 56-60.
- (Jani DK, Nesari MT, Vijayakumar D, Loriaux, Lynn D. Diabetes and the Ebers Papyrus: 1552 BC. The Endocrinologist 2006; 16(2): 55-6.
- Barthold SW. Unsung heroes in the battle against diabetes. ILAR: 2004; 45; 227-30.
- Park K. Park’s Text Book of Preventive and Social Medicine. 20th ed. Jabalpur India: Banarasidas Bhanot; 2009: 341-345.
- Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. International Diabetes Federation, 3rd ed. Belgium: 2006; 15-103.
- Gupta OP, Pathak S. Pandemic trend in prevalence of diabetes mellitus and associated coronary heart disease in India: Their cause and presentation. Internal. Jour. Of Diab in developing countries 2003; 23: 37-49.
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes. Diabetes Care 2004; 27 (5): 1047-1053.
- Ayyub Ali S. Tarjuma Zakhira Sabit Bin Qurrah. Aligharh: Litho Printers; 1987: 280.
- Qarshi MH. Jamiul Hikmat. Vol. II. Lahore: Shaikh Mohammad Bashir & Sons; YNM: 378-379.
- Khan M Ajmal. Haziq. Delhi: Jaseem Book Depot; 1983: 383-390.
- Jeelani G. Makhzane Hikmat, Vol. II. Lahore: Shaikh Mohammad Bashir Sons; 1996: 63-88.
- Khan A. Bayaze Ajmal. New Delhi: Aijaz Publishing House; 1995: 146-147.
- Nikhat S, Khan JA, Ahmad G. Some Experimentally Proved Herbs in Peptic Ulcer Disease. IJPSR, 2012; Vol. 3(8): 2387-2392.
- Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population-based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health 2000; 54: 173–177.
- Shamkant B. Badgujar, Vainav V. Patel, Atmaram H. Bandivdekar & Raghunath T. Mahajan. Traditional uses, phytochemistry and pharmacology of Ficus carica: A review, Pharmaceutical Biology, 2014; 52(11): 1487-1503
- Iffat Ara, Syeda Hina Naqvi, Najeeb Ur Rehman and Mohammad Moiz Qureshi, Comparative Antioxidative and Antidiabetic Activities of Ficus Carica Pulp, Peel and Leaf and their Correlation with Phytochemical Contents. Pharm Res 2020, 4(2): 000197.
- Ibn Hubal. Kitabul Mukhtarat Fil Tibb, (Urdu translation by CCRUM). 2nd. New Delhi: Ministry of H & FW, Govt. of India; 2004:
- Ghani N. Khazainul Advia. New Delhi: Idarae Kitabul Shifa; YNM:
- Nadkarni KM. Indian Plants and Drugs. New Delhi: Srishti Book Distributors; 2005: 120.
- Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Vol.5th. Dehradun: Oriental Enterprises; 2003:
- Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. 6th ed. New Delhi: National Institute of Science Communication and Information Resources CSIR; 2002.
54. Ibne Al Baytar. Al Jami Li Mufradat Al Adviya wal Aghziya, (Urdu translation by CCRUM). Vol. Ist. New Delhi: Ministry of H & FW, Govt. of India; 2003.
A randomized, single-blind, standard-controlled clinical trial was conducted to assess the therapeutic efficacy of
Anjeer (Ficus carica) in the management of Type 2 Diabetes Mellitus (T2DM), traditionally referred to as Ziabetus Shakri.
Sixty confirmed T2DM patients were randomly assigned into two groups: Group A (Test) and Group B (Control), with 30
participants in each. Group A received the investigational drug (Ficus carica) at a dosage of 3 grams twice daily, while Group
B was administered Metformin 500 mg (Cipla), one tablet twice daily, over a period of 45 days.
The findings demonstrated that the test formulation significantly improved certain subjective symptoms, including
fatigue (p<0.001) and unexplained weight loss (p<0.01). However, no statistically significant changes were observed in
polyuria, polydipsia, polyphagia, or progressive weakness (p>0.05). Regarding objective parameters, Group A exhibited
notable improvements in fasting blood sugar (FBS), postprandial blood sugar (PPBS), urine glucose levels (p<0.01), and
glycated hemoglobin (HbA1c) (p<0.05). In contrast, the control group did not show statistically significant changes in FBS
and urine glucose (p>0.05).
These results suggest that Ficus carica may offer potential as an adjunctive treatment for T2DM, particularly in
alleviating specific clinical symptoms and improving glycemic control.
Keywords :
Ziabetus Shakari, Diabetic Mellitus, Anjeer, Metformin, HbA1c.